CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Lutikizumab

Phase 3
AbbVie Inc. (ABBV)

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
ABBVPhase 2

Lutikizumab Phase 2 Est. Readout

Lutikizumab
Sep 2027~STALE
CT.gov
00%
May '27
ABBVPhase 2

Lutikizumab Phase 2 Est. Readout

Lutikizumab
May 2027~STALE
CT.gov
00%
Drug Information

Target Indication

Hidradenitis Suppurativa

Clinical Trial

NCT06524635

Last updated: 1/8/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.